| Issuer | % of Class | Filed |
|---|---|---|
|
Aadi Bioscience, Inc.
13D/A
Amendment 4
WHWK · 00032Q104
|
4.9% |
3/6/2025
Event 3/4/2025
|
|
Aadi Bioscience, Inc.
13D/A
Amendment 3
WHWK · 00032Q104
|
9.2% |
12/23/2024
Event 12/19/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.